1. Home
  2. ALEX vs OGN Comparison

ALEX vs OGN Comparison

Compare ALEX & OGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Alexander & Baldwin Inc. REIT Holding Company

ALEX

Alexander & Baldwin Inc. REIT Holding Company

HOLD

Current Price

$20.81

Market Cap

1.5B

Sector

Real Estate

ML Signal

HOLD

Logo Organon & Co.

OGN

Organon & Co.

HOLD

Current Price

$6.61

Market Cap

1.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ALEX
OGN
Founded
1870
1923
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.5B
1.8B
IPO Year
2012
2020

Fundamental Metrics

Financial Performance
Metric
ALEX
OGN
Price
$20.81
$6.61
Analyst Decision
Hold
Hold
Analyst Count
3
4
Target Price
$21.00
$11.75
AVG Volume (30 Days)
682.5K
4.0M
Earning Date
01-01-0001
05-14-2026
Dividend Yield
6.73%
1.22%
EPS Growth
7.23
N/A
EPS
0.89
0.72
Revenue
$206,673,000.00
$6,216,000,000.00
Revenue This Year
N/A
$0.42
Revenue Next Year
$3.08
$1.67
P/E Ratio
$23.38
$9.17
Revenue Growth
N/A
N/A
52 Week Low
$15.07
$6.18
52 Week High
$21.03
$15.88

Technical Indicators

Market Signals
Indicator
ALEX
OGN
Relative Strength Index (RSI) 65.92 32.93
Support Level $20.73 $6.34
Resistance Level $21.03 $7.87
Average True Range (ATR) 0.02 0.30
MACD -0.02 -0.10
Stochastic Oscillator 71.43 4.39

Price Performance

Historical Comparison
ALEX
OGN

About ALEX Alexander & Baldwin Inc. REIT Holding Company

Alexander & Baldwin Inc is a Hawaii commercial real estate company. The group owns, operates, and manages million square feet of retail, industrial, and office space in Hawaii. It is a real estate investment trust (REIT) and the owner of grocery and drug-anchored retail centers in the state. It functions through two segments namely Commercial Real Estate and Land Operations. The Commercial Real Estate segment owns and manages retail, industrial spaces, and also urban ground leases in Hawaii, thereby accounting for a majority of the company's revenue. The Land Operations segment actively manages the company's land and real estate-related assets and makes optimum utilization of these assets. Geographically, the activities are carried out across the United States.

About OGN Organon & Co.

Organon & Co is a science-based pharmaceutical company that develops and delivers health solutions through a portfolio of prescription therapies within women's health, biosimilars, and established brands. The Company's operations include the following product portfolio: Women's health, Biosimilars and Established medicines. Geographically, it derives a majority of its revenue from Europe and Canada followed by the United States and then Asia Pacific and Japan. The company generates the majority of its revenue from the Established Brands product portfolio.

Share on Social Networks: